Insider trades
Neil Stahl, EVP of Regeneron Pharmaceuticals REGN, has filed 0 purchases and 16 sales on the open market. The latest trade was on 24/12/16.
Neil Stahl
EVP Research and Development
- First filing
- 23/08/23
- Trades
- 35 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- No record
- Last trade
- 24/12/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
REGN | Open-market sale10b5-1 plan | 24/08/08 | 24/08/12 | 5,197 sh6 trades | $1,084.54avg. | $5,636,346.27 | −9.2% |
REGN | Open-market sale | 24/02/07 | 24/02/08 | 8,037 sh7 trades | $950.35avg. | $7,637,953.96 | −13.4% |
REGN | Open-market sale | 23/08/22 | 23/08/23 | 11,665 sh3 trades | $840.98avg. | $9,810,082.23 | −18.0% |